Over £6.5billion ($8.9billion) invested in UK scaleup businesses in Q2 2021
- 7 percent rise in the number of deals completed in Q2 2021
- Investment in early-stage businesses on the rise
- Global VC investment in biotech flourishes...
Global Venture Capital (VC) investors continue to deploy record amounts of money into UK scaleups with nearly £17bn raised in the first half of 2021. This already surpasses the total sum raised in the whole of last year according to Venture Pulse – a quarterly report published by KPMG Private Enterprise.
The research published today using data supplied by PitchBook recorded more than £6.5billion invested into fast-growth UK businesses in Q2 21. A strong COVID-19 vaccination programme and greater business confidence in the post-Brexit environment resulted in 708 deals being completed in Q2 21, up 7 percent on the previous quarter.
Fintech and healthtech businesses attracted the largest deals in Q2 21, including a $500million (£360million) raise by B2B payments firm SaltPay, a $330million+ (£240million) raise over two rounds by AI-powered drug discovery company Exscientia, a $453million (£322million) raise by digital bank Starling Bank, and a $130million (£94million) raise by digital health company Huma. While later-stage deals continued to attract the majority of investment, interest in earlier stage deals grew, with more businesses beginning to raise Series A and smaller rounds.
To read the orginal article please
CLICK HERE.
